Florence Healthcare Announces the Launch of the Site Enablement League to Accelerate Clinical Trial Innovation and Enhance Site Experience
Revolutionizing Clinical Trials: Site Enablement League Unites Industry Leaders to Accelerate Cures and Optimize Site Experience
ATLANTA, May 9, 2023 (Newswire.com) - Florence Healthcare, the leading provider of Site Enablement solutions, is proud to announce the launch of the Site Enablement League, a groundbreaking initiative that brings together clinical trial leaders from research sites, sponsors, patients, CROs and other Site Enablement vendors to collaborate and accelerate the development of cures.
By focusing on streamlining processes, implementing advanced technologies, and fostering effective communication among all stakeholders, the Site Enablement League aims to create a more agile and innovative clinical research environment that ultimately leads to faster development of life-saving treatments.
The Site Enablement League is dedicated to enhancing the trial site experience and driving industry-wide change through technology, process improvements, and best practices. Its annual working groups will focus on specific areas of site enablement, such as site-sponsor-CRO collaborative technology design, standard operating procedures, and industry-wide guidance documents. These targeted efforts will help to build stronger partnerships between all the key stakeholder groups in the clinical trial lifecycle and close the cure acceleration gap - the capacity issue facing our industry that is impeding more cures from getting to market faster.
Members of the Site Enablement League are focused on helping lead the changes needed to move the clinical trial industry forward, as well as establishing themselves as Thought Leaders in the future of site enablement and trial design.
Currently, 55 member companies have senior leader representation in the League, including Flatiron Health, Helio Genomics, PharPoint Research LLC., Thomas Jefferson University, HonorHealth and Icahn School of Medicine at Mt. Sinai. [See the complete list below]. These forward-thinking, innovative clinical trial organizations recognize the potential of the League to transform the clinical research landscape through a strong focus on site enablement.
Catherine Gregor, Chief Clinical Trial Officer for Florence and Executive Chair of the Site Enablement League, commented on the initiative saying, "The Site Enablement League represents a new era of collaboration and innovation in the clinical trial industry. By emphasizing site enablement and bringing together the brightest minds from research sites, sponsors, CROs, and patient advocates, we are creating a powerful network of resources and expertise that will drive meaningful change and ultimately lead to the faster development of life-saving treatments for patients worldwide."
The Site Enablement League is now accepting membership applications from organizations across the clinical research spectrum. To learn more about the League, the importance of site enablement, and how to join, visit https://florencehc.com/site-enablement-league/.
Current Site Enablement League Members
Currently, there are 55 member companies represented in the Site Enablement League including, but not limited to: Accel Research Sites Network, Allina Health, Aperio Clinical Outcomes LLC, Bon Secours Mercy Health, Drexel University, College of Medicine, Flatiron Health, Helio Genomics, HonorHealth, Icahn School of Medicine at Mount Sinai, Javara, Inc., Maryland Oncology Hematology, National Marrow Donor Program, Neurology Associates PA, Neurotech LLC, Northwell Health, Northwest Georgia Oncology Centers, PC., Partners in Innovation, Education, and Research Consortium, LLC (PIER), PharPoint Research, Inc., Prostate Cancer Clinical Trials Consortium, LLC, Providence St. Joseph Health, Rocky Mountain Clinical Research LLC., SiteBridge Research, Inc., Spartanburg Regional Health Services District, Inc, The Medical College of Wisconsin, Thomas Jefferson University, University of South Florida, Zoll Respicardia, Inc, as well as three of the top five global pharma organizations, two of the top three global CROs, and several other academic medical centers, health systems, and research networks globally.
Source: Florence Healthcare